Dr. Daniel Amen shares his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...

The study, published March 6 in Nature Medicine, shows that the brain’s immune cells, called microglia, play a more powerful ...

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

A single, freely available, noninvasive brain scan done in just a few minutes during midlife can predict what chronic ...

The study used blood proteins to analyze the biological age of brains and other organs compared to the person's actual age.

Tuesday night, the Alzheimer’s Association hosted a kick-off party for the annual “Walk to End Alzheimer’s”. The 2-mile walk, ...

Participants with amyloid buildup (indicating higher risk for Alzheimer’s) did not experience emotional distress. In fact, ...